Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer

INTRODUCTION: Inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) is an effective therapeutic tool for lowering low-density lipoprotein cholesterol (LDL-C). There is no available evidence on the efficacy and safety of PCSK9 inhibitors in non-cardiovascular diseases, particularly cancer. T...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arch Med Sci
Autors principals: Momtazi-Borojeni, Amir Abbas, Nik, Maryam Ebrahimi, Jaafari, Mahmoud Reza, Banach, Maciej, Sahebkar, Amirhossein
Format: Artigo
Idioma:Inglês
Publicat: Termedia Publishing House 2019
Matèries:
Hot Topics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524180/
https://ncbi.nlm.nih.gov/pubmed/31110520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2019.84732
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars